Skip to main content

TEVA 01A (Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg)

Pill with imprint TEVA 01A is Red & White, Capsule-shape and has been identified as Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Aspirin/dipyridamole is used in the treatment of ischemic stroke, prophylaxis and belongs to the drug class platelet aggregation inhibitors. There is positive evidence of human fetal risk during pregnancy. Aspirin/dipyridamole 25 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 01A

Aspirin and extended-release dipyridamole 25 mg / 200 mg TEVA 01A
Aspirin and extended-release dipyridamole 25 mg / 200 mg TEVA 01A
Aspirin and extended-release dipyridamole 25 mg / 200 mg TEVA 01A

Aspirin and Extended-Release Dipyridamole

Imprint
TEVA 01A
Strength
25 mg / 200 mg
Color
Red & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Platelet aggregation inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-3040 (Discontinued)
Inactive Ingredients
acacia, aluminum stearate, silicon dioxide, corn starch, dimethicone, hypromelloses, hypromellose phthalate (31% phthalate, 170 cst), lactose monohydrate, methacrylic acid - methyl methacrylate copolymer (1:1), microcrystalline cellulose, povidone, stearic acid, sucrose, magnesium silicate, tartaric acid, titanium dioxide, triacetin, gelatin, ferric oxide red, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.